Quality GMP-Grade iPSC and Knockin-Ready TARGATT™ iPSC

To jump start iPSC derived therapeutic cell product development; achieve reliable and efficient genome integration with our innovative solutions

Reprogramming From CD34+ Cord Blood

Gene Knockin-Ready

Matching Research iPSC Line is Available

GMP iPSC

Our high-quality GMP-grade iPSCs (ASE-9280) were reprogrammed from CD34+ male cord blood using an episomal reprogramming method and have proven gene editing and differentiation capabilities. The ready-to-use ASE-9280 GMP line and matching research-grade iPSCs (ASE-9250) are available for purchase. Expedite your project timelines by placing your order today!

  • Source cell type: CD34+ Cord Blood, healthy male
  • Reprogramming method: Episomal
  • Master cell bank or working cell bank available
  • Seed cell bank has Drug master file with US FDA
  • Matching Research iPSC Line (ASE-9250) is Available
  • Proven to be genomic stable (karyotype normal) and transgene expression stable post gene editing and differentiation
  • No additional passthrough cost
  • Partner with CIRM (California Institute of Regenerative Medicine) in supplying GMP grade iPSC lines

cGMP-Grade TARGATT™ iPSC (Gene Knock-in Ready)

Are you looking for a starting GMP-grade iPSC line that permits safe and efficient insertion of large DNA fragments for your drug development projects? ASC’s GMP-Grade TARGATT™ Master iPSCs (ASE-9480) are ready for site-specific knock-in of any gene of interest (GOI) up to 20 kb in size. The enhanced iPSCs were generated from ASC’s GMP iPSC Line, ASE-9280. These high-quality iPSCs contain a pre-engineered landing pad where unidirectional gene insertion occurs when facilitated by a unique TARGATT™ integrase. In addition, the TARGATT™ iPSCs can be further differentiated into various lineage-committed cell types (e.g. neural progenitor cells, astrocytes, dopaminergic neurons, cortical neurons, cardiomyocytes, NK, T cell, hematopoietic stem cells and more).

cGMP-Grade TARGATT™ iPSC are:

  • Engineered from ASC’s GMP grade iPSCs (ASE-9280) using MAD7 (No CRISPR/Cas9)
  • GMP SOP
  • All reagents are CGT grade (animal, serum-free)
  • Documentation and QC/QA follow our eQMS
  • Certificate of Analysis provided upon request
  • All testing follows GMP guidelines
  • License-ready and clear IP path to commercialization
  • GMP-Matching research TARGATT™ iPSCs (ASE-9450) are available

targatt

Would you like to learn more about ASC’s iPSCs or TARGATT™™ technology? Contact us today to speak with one of our experts.

cGMP TARGATT™ iPSC-dCell Platform

ASC’s cGMP TARGATT™ iPSC system provides unlimited starting materials and platform for therapeutic cell products. TARGATT™ master iPSCs are pluripotent stem cells with a pre-engineered landing pad, attP site, in the H11 safe genomic locus ready for repeated, fast, and efficient gene knock-in by TARGATT™ integrase. The resulting gene edited iPSC can be differentiated to make unlimited, truly off-the-shelf cell products named iPSC-dCell, in which “dCell” stands for “differentiated cell”. We aim to address pain points / bottlenecks through innovative iPSC and TARGATT™ gene editing technologies.

Pain points of current autologousasc_gmp_ipsc_platform cell therapy approaches include:

  • One product for one patient
  • Takes months to make
  • Patients do not have time
  • Multiple doses cost millions of $$$
  • <5% population has access

Advantages of ASC’s TARGATT™ iPSC-dCell Platform

  • Engineered from ASC’s GMP grade iPSCs using TARGATT™ (No CRISPR/Cas9)
  • Streamlined manufacturing and testing follow cGMP guidelines, with product consistency from one batch to another
  • License-ready and clear IP path to commercialization
  • One product for many patients
  • Off-the-shelf products offering life-saving, on-demand treatment

Why Applied StemCell?

We understand working with iPSCs remains difficult, and you may encounter several challenges. At ASC our stem cell and gene editing experts are ready to help you every step of the way.

  1. Send in your construct design for review. Our experts can help you enhance your design.
  2. Our team can design research and GMP projects in parallel OR generate a matching research grade cell line for preliminary testing.
  3. Downstream assay services are available: cell-based assays, in vivo animal model testing / PK / PD / ADME, and more.
  4. Regulatory filing support: CMC / IND support.

ipsc-service

GMP iPSCs Stages

Products and Services

Catalog ID# Product Name Format Size Price QTY
-
-
Frozen
-
Frozen
-
Service
-
  • iPSC Characterization: Direct Differentiation to Three Germ Layers

    Figure 1:  Direct differentiation of ASE-9280 GMP Grade iPSCs to three germ layers. Staining for lineage-specific biomarkers of three germ layers after direct differentiation of the GMP hiPSC line, ASE-9280. The ASE-9280 GMP hiPSC line was differentiated to specific lineages of the germ layers using well-established and optimized protocols. Immunostaining for biomarkers of each lineage was performed. Cells were also co-stained with nuclear marker, DAPI (blue). Biomarkers: Ectoderm (EC) marker: Pax6 (green) and Tuj1 (red); Mesoderm (ME) marker: Brachyury (red) and GATA-4 (green); Endoderm (EN) marker: Fox2A (red) and Sox-17 (green).

    iPSC Characterization: ASC’s cGMP iPSC Differentiate to Various Cell Types

    ASC’s cGMP iPSC Differentiate to Various Cell Types

    Hepatocytes iPSC Differentiate

     

    ASC’s cGMP iPSC Differentiate to Islet Organoids iPSC Derived Pancreatic OrganoidsBright-field image of ASE-9280 iPSC-derived pancreatic organoids

    Fluorescent Confocal-Fluorescent confocal image of ASE-9280 iPSC derived pancreatic organoids (insulin, NKX6.1, and DAPI)
    Data provided by Essentia

     

    ASC’s cGMP iPSC Differentiate to Kidney Organoids
    cGMP iPSC Differentiate to Kidney Organoids

     

    ASC’s cGMP iPSC Differentiate to Beating Cardiomyocytes

    Click below to watch cGMP iPSC Differentiate to Beating Cardiomyocytes

MTA Agreement

Material Transfer Agreement

IMPORTANT! PLEASE READ CAREFULLY BEFORE SUBMITTING AN ORDER. THIS IS A CONTRACT.

This Material Transfer Agreement (“MTA”) is between you (“Purchaser”) and the Applied StemCell, Inc. a California company, having its principal place of business at 521 Cottonwood Drive Suite 111, Milpitas, CA 95035 USA (“ASC”). Purchaser must have an approved, current ASC account to place an order. This MTA is effective for a period of five (5) years as of the last date of execution by the parties and governs the purchase and use of all ASC Materials under the terms and conditions set forth below.

TERMS AND CONDITIONS

Definitions

“ASC Material(s)” means materials acquired from ASC as documented on an ASC Sales Order, such as iPS Cell lines.

"ASC Sales Order" means an order submitted for ASC Materials in a form and format as determined by ASC from time to time. "Biological Material(s)" means ASC Materials, Progeny, Unmodified Derivatives and Modifications, either individually or jointly. "Commercial Use" means the sale, license, lease, export, transfer or other distribution of the Biological Materials to a person or entity not party to this MTA for financial gain or other commercial purposes and/or the use of the Biological Material: (a) to provide a service to a person or entity not party to this MTA for financial gain; (b) to produce or manufacture products for general sale or products for use in the manufacture of products ultimately intended for general sale (c) in connection with ADME (Absorption, Distribution, Metabolism and Excretion) testing; (d) in connection with drug potency or toxicity testing (e) in connection with proficiency testing service(s), including but not limited to, providing the service of determining laboratory performance by means of comparing and evaluating calibrations or tests on the same or similar items or materials in accordance with predetermined conditions; or (f) for research conducted under an agreement wherein a for-profit entity receives a right whether actual or contingent to the results of the research. Commercial Use specifically does not include Industry Sponsored Academic Research.

“Contributor(s)” means an organization(s) and/or individual(s) providing original material to ASC for deposit.

"Industry Sponsored Academic Research" means research sponsored by a for-profit organization carried out at a non-profit organization and by the non-profit organization’s employees. "Investigator" means the Purchaser’s principal scientist or researcher using the Biological Material(s). "Modification(s)" mean substances created by Purchaser which contain and/or incorporate a significant or substantial portion of ASC Material. "Progeny" means an unmodified descendant from the ASC Materials, such as virus from virus, cell from cell, or organism from organism. "Purchaser(s)" means the organization purchasing and receiving ASC Material pursuant to this MTA. "Unmodified Derivative(s)" mean substances created by Purchaser that constitute an unmodified functional sub-unit or product not changed in form or character and expressed by the ASC Material provided by ASC. Unmodified Derivatives include, but are not limited to, subclones of unmodified cell lines, purified or fractionated subsets of materials provided by ASC, proteins expressed by DNA/RNA supplied by ASC, or monoclonal antibodies secreted by a hybridoma cell line.

Scope of Use

Subject to the terms of this MTA, Purchaser’s Investigator may make and use the Biological Materials provided to Purchaser by ASC for research purposes only in Purchaser’s Investigator’s laboratory only. The Biological Materials are not intended for use in humans. Purchaser agrees that Biological Materials designated as biosafety level 2 or 3 constitute known pathogens and that other Biological Materials not so designated may be pathogenic under certain conditions. Purchaser assumes all risk and responsibility in connection with the receipt, handling, storage, disposal, transfer and Purchaser’s use of the Biological Materials including without limitation taking all appropriate safety and handling precautions to minimize health or environmental risk. Purchaser agrees that any activity undertaken with the Biological Materials will be conducted in compliance with all applicable guidelines, laws and regulations, and that Purchaser will obtain all permits, licenses or other approvals required by any governmental authority in connection with purchaser’s receipt, handling, storage, disposal, transfer and use of the Biological Materials.

Purchaser shall not distribute, sell, lend or otherwise transfer to a person or entity not party to this MTA the Biological Material, as defined above, for any reason, without ASC’s prior written agreement.

Any Commercial Use of the Biological Material is strictly prohibited without ASC’s prior written consent. Purchaser acknowledges and agrees that Purchaser’s use of certain Biological Material may require a license from a person or entity not party to this MTA, or be subject to restrictions that may be imposed by a person or entity not party to this MTA (“Third Party Terms”). To the extent of ASC’s knowledge of the existence of any such applicable rights or restrictions, ASC will take reasonable steps to identify the same, either in ASC’s catalog of ASC Materials and/or through ASC’s customer service representatives, and to the extent they are in the possession of ASC, ASC shall make information regarding such Third Party Terms reasonably available for review by Purchaser upon request. Purchaser expressly acknowledges that if there is a conflict between this MTA and the Third Party Terms, the Third Party Terms shall govern. Use of the Biological Materials may be subject to the intellectual property rights of a person or entity not party to this MTA, the existence of which rights may or may not be identified in the ASC catalog or website, and ASC makes no representation or warranty regarding the existence or the validity of such rights. Purchaser shall have the sole responsibility for obtaining any intellectual property licenses necessitated by its possession and use of the Biological Materials.

The use permitted under this MTA for Industry Sponsored Academic Research extends only to the academic research carried out at the non-profit organization and the non-profit organization’s employees. Any non-profit Purchaser using the Biological Materials in connection with Industry Sponsored Academic Research agrees to notify the industrial sponsor that any use of the Biological Materials by the industry sponsor will require a separate license from ASC and/or its Contributors and that ASC and/or its Contributors are under no obligation hereunder to license any Biological Materials to any such industry sponsor.

Warranty; Warranty Disclaimer

ASC warrants that (a) cells and microorganisms included in the ASC Material shall be viable upon initiation of culture for a period of thirty (30) days after shipment thereof from ASC and (b) any ASC Material other than cells and microorganisms shall meet the specifications on the applicable ASC Material product information sheet, certificate of analysis, and/or catalog description until the expiration date on the applicable ASC Material’s product label (such thirty (30) day period, or period until the expiration date, referred to herein as the “Warranty Period”). Purchaser’s exclusive remedy, and ASC’s sole liability, for breach of the warranties set forth in this paragraph is for ASC to, at ASC’s sole option, either (i) refund the fee paid to ASC for such ASC Material (exclusive of shipping and handling charges), or (ii) replace the ASC Material. The warranties set forth in this paragraph apply only if Purchaser handles and stores the ASC Material as described in the applicable ASC Material product information sheet. To obtain the exclusive remedy, Purchaser must report the lack of viability or non-conformation to specifications to ASC’s Technical Service Department within the applicable Warranty Period. Any expiration date specified on the ASC Material shipment documentation states the expected remaining useful life, but does not constitute a warranty or extend any applicable Warranty Period. Except as expressly provided above, the ASC Material and any technical information and assistance provided by ASC are provided as-is, without warranties of any kind, express or implied, including but not limited to any implied warranties of merchantability, fitness for a particular purpose, typicality, safety, accuracy and/or non-infringement.

Purchaser acknowledges that the ASC Material and any technical information and assistance provided by ASC are developed and provided exclusively for research purposes, and Purchaser agrees to use the same at its sole risk. Purchaser agrees that ASC and its Contributors will not be liable for any loss, claim or demand made by Purchaser, or made against Purchaser by any other party, due to or arising from the use of the ASC Material by Purchaser, except to the extent permitted by law when caused by the gross negligence or willful misconduct of ASC.

Limitation of Liability

In no event shall ASC or its Contributors be liable for any use of the Biological Material by Purchaser, for any loss, claim, damage, or liability, of whatever kind or nature, which may arise from or in connection with this MTA or the use, handling, storage, or disposal of the Biological Material. ASC’s liability to Purchaser for any claim related to or arising from this MTA or the Biological Material, whether in contract, warranty, tort, or otherwise, shall be limited to the amount paid by Purchaser for the Biological Material. In no event shall ASC be liable for any indirect, special, incidental, consequential, or punitive damages, including without limitation, loss of profits or loss of use, even if ASC has been advised of the possibility of such damages. The limitations of liability set forth in this MTA shall survive termination or expiration of this MTA for any reason.